The effect of turmeric-Boswellia formulation (Rhuleave-K) in posture-related low back soreness and discomfort: A randomized double blinded placebo controlled trial.

Abstract

Background: Poor posture from work or lifestyle habits is a common cause of low back soreness and discomfort. This study investigates the potential of Rhuleave-K, a turmeric-Boswellia formulation for managing these symptoms.

Objective: To evaluate the efficacy of Rhuleave-K (500 mg) over 15 days in alleviating posture-related low back soreness and discomfort in human participants.

Methods: This randomized, placebo-controlled, double-blinded, parallel arm study involved 52 subjects aged 18-70 years, with an equal male to female ratio of 1:1, and a 15 days intervention period. The inclusion criteria were a posture-related low back soreness and discomfort for at least 2-3 weeks with a pain intensity of greater than or equal to 5 on numerical rating scale. The primary outcome measure was a pain intensity difference from baseline to day 7 and day 15. Secondary outcome measures were a categorical pain relief scale and Oswestry disability index (ODI).

Results: There was a significant decrease in the pain intensity (p < 0.001) compared to placebo at the end of 15 days of study in the Rhuleave-K group. After 7 days of supplementation of Rhuleave-K, there was a 56% reduction in pain intensity and by the end of the study, there was 98.5% reduction. In the responder profile of those having greater than or equal to 50% of max total pain relief, all 26 was in Rhuelave-K group and 3 were in placebo group. The ODI had significant 27% and 98% reduction in the disability index at day 7 and 15 respectively for Rhuleave-K group and placebo group had 1% and 3% change.

Conclusion: Posture-related low back soreness and discomfort was significantly reduced by Rhuleave-K at 500 mg dose. It is hence evident from this study's outcome that the Rhuleave-K can be a safe and effective alternative for the short-term management of lower back discomfort.